Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older
Clinical trial NCT01884519 · COMPLETED
Trial details
- NCT number
- NCT01884519
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2013-08-02
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.